Skip to main content
OpenTrials

Clinical trial condition

Primary Peritoneal Cancer

Explore clinical trials studying Primary Peritoneal Cancer. Study availability and eligibility vary by location and protocol.

91 public trials 21 recruiting studies
Refine in advanced search Browse all conditions

Primary Peritoneal Cancer trial results

Recruiting

Phase II IMNN-001 (Also Known as GEN-1) on SLL With BEV and NACT, Newly Diagnosed Advanced Ovarian, Fallopian Tube or Primary Peritoneal Cancer

NCT05739981

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations
  • Johns Hopkins Medicine SKCCC Baltimore, Maryland, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • OU Health, Stephenson Cancer Center Oklahoma City, Oklahoma, United States
  • University of Texas MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Recruiting

A Study to Assess Adverse Events and Change in Disease Activity in Participants With Platinum-Resistant Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression Treated With Intravenously (IV) Infused Mirvetuximab Soravtansine

NCT06682988

Conditions
Adnexal Diseases, Advanced High-Grade Epithelial Ovarian Cancer, Fallopian Tube Cancers, +12 more
Locations
  • First Physicians Group /ID# 272180 Sarasota, Florida, United States
  • St. Elizabeth Medical Center - Edgewood /ID# 272113 Edgewood, Kentucky, United States
  • Baptist Health Lexington /ID# 272211 Lexington, Kentucky, United States
  • UMass Memorial Medical Center - Belmont Street /ID# 272122 Worcester, Massachusetts, United States
View all 52 locations
View Trial Details
Recruiting

REVITALIZE: RCT to Reduce Fatigue in Adults With Ovarian Cancer on PARP Inhibitors

NCT06710548

Conditions
Adnexal Diseases, Advanced Ovarian Carcinoma, Endocrine Gland Neoplasms, +21 more
Locations
  • University of Colorado Cancer Center-Anschutz Aurora, Colorado, United States
  • University of Colorado Boulder Boulder, Colorado, United States
  • Massachusetts General Hospital-Cancer Center Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
View Trial Details
Recruiting

A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab

NCT04590326

Conditions
Adnexal Diseases, Disease Attributes, Endocrine Gland Neoplasms, +25 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • The City of Hope Orange County Lennar Foundation Cancer Center Irvine, California, United States
  • Chao Family Comprehensive Cancer Center Orange, California, United States
  • H. Lee Moffitt Cancer Center Tampa, Florida, United States
View all 24 locations
View Trial Details
Recruiting

Study of AVZO-021 in Patients With Advanced Solid Tumors

NCT05867251

Conditions
Adnexal Diseases, Advanced Solid Tumor, Breast Diseases, +35 more
Locations
  • Yale Cancer Center New Haven, Connecticut, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Perlmutter Cancer Center at NYU Langone Hospital - Long Island Mineola, New York, United States
View all 13 locations
View Trial Details
Recruiting

A Beta-only IL-2 ImmunoTherapY Study

NCT05086692

Conditions
Acral Melanoma, Adenocarcinoma, Adenoma, +120 more
Locations
  • Sharp Memorial Hospital San Diego, California, United States
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • Providence Saint John's Health Center Santa Monica, California, United States
  • Boca Raton Regional Hospital Boca Raton, Florida, United States
View all 27 locations
View Trial Details

Related conditions